Results 61 to 70 of about 125,630 (314)

Development of an analytical method for detecting triterpene alcohols in camellia oil and evaluation of their anti‐inflammatory effects

JSFA reports, EarlyView.
Abstract Background Camellia oil is a characteristic Chinese plant oil and is hailed as “the olive oil of the East”. However, there is a significant difference in the active ingredient between it and olive oil, which consequently leads to different effects.
Hengguang Cheng, Qing Jiang, Xiaoxia Li, Yunjie Jiang, Tinghuan Fang, Lirong Tang   +5 more
wiley   +1 more source

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg   +11 more
wiley   +1 more source

Severity of eczema and mental health problems in Japanese schoolchildren: The ToMMo Child Health Study

Allergology International, 2018
Background: The association between eczema and mental health problems in schoolchildren has been underexplored. We aimed to investigate this association with the validated questionnaires.
Yasutaka Kuniyoshi, Masahiro Kikuya, Masako Miyashita, Chizuru Yamanaka, Mami Ishikuro, Taku Obara, Hirohito Metoki, Naoki Nakaya, Fuji Nagami, Hiroaki Tomita, Atsushi Hozawa, Ichiro Tsuji, Shigeo Kure, Nobuo Yaegashi, Masayuki Yamamoto, Shinichi Kuriyama   +15 more
doaj   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source

Analysis of heritability and environmental factors in preschool children with eczema: a case-control study

Scientific Reports
Eczema is common in children, and its onset is affected by both genetic and environmental factors. We investigated the effects of genetic and environmental factors on the incidence of eczema in preschool children.
Qingfang Du, Lei Zhang, Chongzhi Ma, Li Yang, Jun Tian, Zijian Cao   +5 more
doaj   +1 more source

Drug Hypersensitivity: A Correlation Study From Histopathology to Clinic

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Drug hypersensitivity (DH) can present with varied clinical and pathological manifestations that may mislead the referring physician. Available data regarding the concordance between pathological diagnosis and clinical findings in DH are scarce.
Olivier Philip, Morgane Stichelbout, Marie Verhasselt‐Crinquette, Baptiste Mille, Delphine Staumont‐Sallé, Frédéric Dezoteux   +5 more
wiley   +1 more source

Eczema herpeticum in a child in the first year of life: a clinical case report [PDF]

, 2020
H. M. Vahitov, Alfiya Makhmutovа, L. M. Ziyatdinova, M S Pospelov   +3 more
openalex   +1 more source

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg   +12 more
wiley   +1 more source

Quality of Care and Management of Atopic Dermatitis Across Different Levels of Healthcare—A Survey-Based Patient Experience

Journal of Patient Experience
Atopic dermatitis (AD) is a chronic and fluctuating disease. Optimal management of AD and related comorbidities requires seamless coordination across multiple layers of the healthcare system.
Thrasyvoulos Tzellos, Synne Ildahl Svendsen, Mari Øvergaard, Eldrid Oftestad, Mari Lahelma, Anna-Kaisa Asikainen, Randeep Mandla   +6 more
doaj   +1 more source

Histopathological Aspects of Common Immune Checkpoint Inhibitors Induced Skin Toxicities

JEADV Clinical Practice, EarlyView.
ABSTRACT Background The histological characteristics of checkpoint inhibitors‐related adverse events (cirAEs) are not well studied and there are conflicting data regarding their similarities and differences with their idiopathic counterparts. Objectives To investigate the histological characteristics of the most common cirAEs.
Christina Kemanetzi, Konstantinos Lallas, Elizabeth Lazaridou, Mattheos Bobos, Aikaterini Kyriakou, Myrto Trakatelli, George Lazaridis, Evangelos Karamitrousis, Dimitrios Dionysopoulos, Konstantia Loga, Aimilios Lallas, Stavroula Pervana, Zoe Apalla   +12 more
wiley   +1 more source